AscendiantLogo Better

Ascendiant Capital Markets, LLC

Corporate Finance

See Our Impact

Ascendiant has led or participated in over $2 billion in financing transactions.

Corporate Finance

Ascendiant Capital Markets provides equity capital, debt financing, and related strategic guidance and advisory services to public and private companies, while generating investment opportunities for institutional, accredited, and strategic investors. Ascendiant’s Investment Banking division also assists private companies interested in going public.

Ascendiant has led or participated in over $2 billion in financing transactions across a wide range of industry sectors.

Ascendiant’s Investment Banking team has a broad network of capital providers that include investment funds, hedge funds, asset managers, senior and mezzanine lenders, family offices, sovereign wealth funds, trading firms, and fund advisors. The principals of Ascendiant manage two in-house fund entities: Ascendiant Capital Fund, LP and Ascendiant Focus Fund, LP.

Ascendiant’s senior-level Investment Bankers have expertise in all aspects of a company’s capital structure, and have provided all flavors of equity capital and debt financing including common and preferred stock, convertible debentures, bridge loans, senior and subordinated debt, and warrants.

In addition, the members of Ascendiant’s Investment Banking team have held executive and operational roles within public and private companies, giving them valuable perspective and insight.

Services include:

  • Private Placements of Equity and Equity-Linked Securities
  • Registered Direct Offerings
  • Underwritten Offerings (IPOs, Follow-Ons, Rights Offerings, At-the-Market Offerings)
  • Debt Financing (Bridge Loans, Senior and Subordinated Debt Placement)
  • Strategic business and financial advisory services


Contact Us
Our Latest Financing Transactions
Ascendiant Client Logos 10
Nasdaq: PAVM Nasdaq: PAVM Nasdaq: PAVM
Nasdaq: PAVM Nasdaq: PAVM Nasdaq: PAVM

$50,000,000

Registered Direct

Financial Advisor

April

2022

Endra Life Science
Nasdaq: NDRA Nasdaq: NDRA Nasdaq: NDRA
Nasdaq: NDRA Nasdaq: NDRA Nasdaq: NDRA

$9,360,000

At-The-Market Offering

Sole Sales Agent

April

2022

ClientLogos 300x150 02
Nasdaq: INTZ Nasdaq: INTZ Nasdaq: INTZ
Nasdaq: INTZ Nasdaq: INTZ Nasdaq: INTZ

$10,700,000

Private Placement

Sole Placement Agent

March

2022

ClientLogos 300x150 01
NYSE American: NILE NYSE American: NILE NYSE American: NILE
NYSE American: NILE NYSE American: NILE NYSE American: NILE

$200,000,000

At-The-Market Offering

Sole Sales Agent

February

2022

YAYO Logo
OTC: YAYO OTC: YAYO OTC: YAYO
OTC: YAYO OTC: YAYO OTC: YAYO

$13,700,000

Private Placement

Placement Agent

January

2022

ClientLogos 300x150 08
Nasdaq: AIRT Nasdaq: AIRT Nasdaq: AIRT
Nasdaq: AIRT Nasdaq: AIRT Nasdaq: AIRT

$12,000,000

At-The-Market Offering

Sole Sales Agent

November

2021

Outlook Therapeutics
Nasdaq: OTLK Nasdaq: OTLK Nasdaq: OTLK
Nasdaq: OTLK Nasdaq: OTLK Nasdaq: OTLK

$10,220,000

Private Placement

Financial Advisor

November

2021

ClientLogos 300x150 08
Nasdaq: NXTP Nasdaq: NXTP Nasdaq: NXTP
Nasdaq: NXTP Nasdaq: NXTP Nasdaq: NXTP

$1,665,000

Private Placement

Sole Placement Agent

October

2021

ClientLogos 300x150 03
Nasdaq: LUCD Nasdaq: LUCD Nasdaq: LUCD
Nasdaq: LUCD Nasdaq: LUCD Nasdaq: LUCD

$70,000,000

Initial Public Offering

Financial Advisor

October

2021

Endra Life Science
Nasdaq: NDRA Nasdaq: NDRA Nasdaq: NDRA
Nasdaq: NDRA Nasdaq: NDRA Nasdaq: NDRA

$20,000,000

At-the-Market Offering

Sole Sales Agent

June

2021

AIRTINC
Nasdaq: AIRT Nasdaq: AIRT Nasdaq: AIRT
Nasdaq: AIRT Nasdaq: AIRT Nasdaq: AIRT

$8,000,000

At-the-Market Offering

Sole Sales Agent

May

2021

MOnaker Group
Nasdaq: MKGI Nasdaq: MKGI Nasdaq: MKGI
Nasdaq: MKGI Nasdaq: MKGI Nasdaq: MKGI

$9,370,000

Private Placement

Sole Placement Agent

March

2021

Ault Global Holdings
NYSE American: DPW NYSE American: DPW NYSE American: DPW
NYSE American: DPW NYSE American: DPW NYSE American: DPW

$200,000,000

At-the-Market Offering

Sole Sales Agent

March

2021

Endra Life Science
Nasdaq: NDRA Nasdaq: NDRA Nasdaq: NDRA
Nasdaq: NDRA Nasdaq: NDRA Nasdaq: NDRA

$12,600,000

At-the-Market Offering

Sole Sales Agent

February

2021

Ault Global Holdings
NYSE American: DPW NYSE American: DPW NYSE American: DPW
NYSE American: DPW NYSE American: DPW NYSE American: DPW

$125,000,000

At-the-Market Offering

Sole Sales Agent

February

2021

Nemaura
Nasdaq: NMRD Nasdaq: NMRD Nasdaq: NMRD
Nasdaq: NMRD Nasdaq: NMRD Nasdaq: NMRD

$24,015,000

Private Placement

Sole Placement Agent

February

2021

Atossa Therapeutics
Nasdaq: ATOS Nasdaq: ATOS Nasdaq: ATOS
Nasdaq: ATOS Nasdaq: ATOS Nasdaq: ATOS

$25,200,000

Registered Direct

Financial Advisor

January

2021

Ault Global Holdings
NYSE American: DPW NYSE American: DPW NYSE American: DPW
NYSE American: DPW NYSE American: DPW NYSE American: DPW

$50,000,000

At-the-Market Offering

Sole Sales Agent

January

2021

Pro Dex
Nasdaq: PDEX Nasdaq: PDEX Nasdaq: PDEX
Nasdaq: PDEX Nasdaq: PDEX Nasdaq: PDEX

$25,000,000

At-the-Market Offering

Sole Sales Agent

December

2020

Ascendiant Client Logos 10
Nasdaq: PAVM Nasdaq: PAVM Nasdaq: PAVM
Nasdaq: PAVM Nasdaq: PAVM Nasdaq: PAVM

$8,100,000

Registered Direct

Financial Advisor

December

2020

Dpw Holdings
NYSE American: NILE NYSE American: NILE NYSE American: NILE
NYSE American: NILE NYSE American: NILE NYSE American: NILE

$40,000,000

At-the-Market Offering

Sole Sales Agent

December

2020

Get To Know Us

Meet the team that makes everything happen. Putting our clients first, and making sure they are successful, is what drives us each and every day. 

Meet The Team
Bradley Wilhite

Bradley J. Wilhite

Co-Founder & Managing Partner

Leadership, Investment Banking

ASCENDiant Mark

Mark A. Bergendahl

Co-Founder & Managing Partner

Leadership
Our Values

Our Values

01/08

Relationships

We’re in the money business, but we’re really in the people business. Investing in long-term relationships with clients is a fundamental principle of our business strategy, and one of the most rewarding and enjoyable aspects of what we do.

Our Values

02/08

Trust

Trust, along with excellent communication, is essential in any relationship. We value honesty, integrity, transparency, and reliability, and pledge to always do our best to earn your trust.

Our Values

03/08

Highest Standards

We’re not here to sell you, we’re here to serve you. That means doing what is best for your company and your shareholders – based on your needs and objectives, not ours. We’ve run businesses, too, and now we run an investment bank – that will always put you first.

Our Values

04/08

Serve Clients

Our goal is not to be the biggest bank, it’s to be the best – for the clients we serve. Your best financial partner, your best advisor, your best strategist, your best resource, your best sounding board. The best an investment bank has to offer.

Our Values

05/08

Success

Here’s our simple business philosophy and formula for success – maximize relationships, not fees. Success for us is a client achieving its goals and realizing its potential. When our capital is structured in a way that truly meets your needs – and allows you to hire more employees, open a new building, expand R&D, move more product, or secure a strategic acquisition, that’s our measure of success.

Our Values

06/08

Experience

Most investors and bankers you meet have never run a business, and even fewer have managed a public company. We have unique perspective and insight from your side of the desk because we’ve been there. We appreciate what you do – tackling challenges and pursuing opportunities – and want to do our best to support you. Let our experience and expertise help you make the best decisions for your company.

Our Values

07/08

Freedom

A public company needs support from a lot of sources to achieve success. That means multiple investors, analysts, shareholders, and yes, investment banks. In short, you need a lot of investment bank friends, not just one. When an investment bank requires exclusivity or a right of first refusal following a capital raise, they are leveraging the relationship and limiting your company’s options. When you work with us, you have freedom, and that’s best for your business.

Our Values

08/08

Respect

Some investment banks are run like a money printing machine – deal after deal, and fees on top of fees. You get calls, e-mails, and texts all hours of the day, night, and weekends, pushing you to accept an offer. That’s not our style, and we’re respectful of your time and your life away from the office. We’ll listen to your needs and objectives, present ideas and solutions, and let you make the call.
Ascendiant News
April 7, 2022
Ascendiant Serves as Financial Advisor on $50,000,000 Registered Direct for PAVmed Inc. (Nasdaq: PAVM)
April 4, 2022
Ascendiant Serves as Sole Sales Agent on $9,360,000 At-The-Market (ATM) Offering for ENDRA Life Sciences, Inc. (Nasdaq: NDRA)
March 10, 2022
Ascendiant Serves as Sole Placement Agent on $10,700,000 Private Placement for Intrusion, Inc. (Nasdaq: INTZ)
February 28, 2022
Ascendiant Serves as Sole Sales Agent on $200,000,000 At-the-Market (ATM) Offering for BitNile Holdings, Inc. (NYSE American: NILE)
January 24, 2022
Ascendiant Initiates Research Coverage on SurgePays, Inc. (Nasdaq: SURG)
January 11, 2022
Ascendiant Serves as Placement Agent on $13,700,000 Public Offering for EVmo, Inc.
December 26, 2021
Ascendiant Initiates Research Coverage on Lucid Diagnostics, Inc. (Nasdaq: LUCD)
December 15, 2021
Ascendiant Initiates Research Coverage on BitNile Holdings, Inc. (NYSE American: NILE)
November 22, 2021
Ascendiant Serves as Sole Sales Agent on $12,000,000 At-the-Market (ATM) Offering for Air T, Inc. and Air T Funding (Nasdaq: AIRT and AIRTP)
November 18, 2021
Ascendiant Serves as Financial Advisor on $10,220,000 Private Placement for Outlook Therapeutics, Inc. (Nasdaq: OTLK), Increases Total Amount to $30,040,000 over Four Transactions
November 17, 2021
Ascendiant Serves as Sole M&A Advisor on Sale of South East Instruments to Pac-Dent, Inc.
November 1, 2021
Ascendiant Initiates Research Coverage on Quantum Computing, Inc. (Nasdaq: QUBT)